Ieq Capital, LLC Vertex Pharmaceuticals Inc Transaction History

Ieq Capital, LLC

$8.04 Billion
Q3 2024

A detailed history of Ieq Capital, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Ieq Capital, LLC holds 22,581 shares of VRTX stock, worth $8.97 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

22,581

Previous 21,093 7.05%

Holding current value

$8.97 Million

Previous $9.89 Million 6.22%

% of portfolio

0.13%

Previous 0.13%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$460.0 - $505.78 $684,480 - $752,600	1,488 Added 7.05%	22,581 $10.5 Million
Q2 2024 Aug 12, 2024	BUY	$392.81 - $485.53 $737,304 - $911,339	1,877 Added 9.77%	21,093 $9.89 Million
Q1 2024 May 08, 2024	BUY	$407.69 - $446.08 $502,681 - $550,016	1,233 Added 6.86%	19,216 $8.03 Million
Q4 2023 Feb 07, 2024	BUY	$343.0 - $410.68 $171,500 - $205,340	500 Added 2.86%	17,983 $7.32 Million
Q3 2023 Nov 03, 2023	BUY	$338.18 - $362.46 $337,841 - $362,097	999 Added 6.06%	17,483 $6.08 Million
Q2 2023 Aug 07, 2023	BUY	$314.42 - $351.91 $515,019 - $576,428	1,638 Added 11.03%	16,484 $5.8 Million
Q1 2023 May 01, 2023	BUY	$283.23 - $323.1 $137,933 - $157,349	487 Added 3.39%	14,846 $4.68 Million
Q4 2022 Feb 03, 2023	BUY	$285.76 - $321.48 $240,038 - $270,043	840 Added 6.21%	14,359 $4.15 Million
Q3 2022 Nov 03, 2022	BUY	$273.83 - $305.53 $1.33 Million - $1.49 Million	4,875 Added 56.4%	13,519 $3.91 Million
Q2 2022 Jul 27, 2022	BUY	$234.96 - $292.55 $376,170 - $468,372	1,601 Added 22.73%	8,644 $2.44 Million
Q1 2022 Apr 26, 2022	BUY	$221.42 - $260.97 $265,482 - $312,903	1,199 Added 20.52%	7,043 $1.84 Million
Q4 2021 Jan 31, 2022	BUY	$177.01 - $223.45 $391,015 - $493,601	2,209 Added 60.77%	5,844 $1.28 Million
Q3 2021 Nov 09, 2021	BUY	$181.39 - $202.99 $222,746 - $249,271	1,228 Added 51.02%	3,635 $659,000
Q2 2021 Jul 29, 2021	SELL	$187.49 - $221.1 $19,123 - $22,552	-102 Reduced 4.07%	2,407 $485,000
Q1 2021 May 04, 2021	BUY	$207.02 - $241.31 $519,413 - $605,446	2,509 New	2,509 $539,000
Q4 2020 Feb 03, 2021	SELL	$207.01 - $276.09 $430,166 - $573,715	-2,078 Closed	0 $0
Q3 2020 Nov 03, 2020	SELL	$255.65 - $303.1 $28,888 - $34,250	-113 Reduced 5.16%	2,078 $565,000
Q2 2020 Jul 31, 2020	SELL	$225.48 - $295.8 $2,931 - $3,845	-13 Reduced 0.59%	2,191 $636,000
Q1 2020 May 07, 2020	BUY	$199.77 - $247.81 $137,441 - $170,493	688 Added 45.38%	2,204 $524,000
Q4 2019 Feb 11, 2020	SELL	$166.71 - $223.91 $88,189 - $118,448	-529 Reduced 25.87%	1,516 $332,000
Q4 2019 Feb 04, 2020	BUY	$166.71 - $223.91 $340,921 - $457,895	2,045 New	2,045 $269,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $102B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ieq Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ieq Capital, LLC with notifications on news.

Account